Evidence map›Paper›PMID 40376717›Full record

ArticleBiotechnology journal2025

Utilizing Stable Gene-Edited Knockout Pools for Genetic Screening and Engineering in Chinese Hamster Ovary Cells.

Jannis Peter Marzluf, Kirchmeier Daniela, Jennifer Klein, Christoph Zehe, Ann-Cathrin Leroux

Abstract read
In one paragraph

Article in Biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jannis Peter MarzlufDepartment of Gene Therapy, University of Ulm, Ulm, Germany.ORCID https://orcid.org/0009-0002-1683-2023
Kirchmeier DanielaSartorius Stedim Cellca GmbH, Ulm, Germany.ORCID https://orcid.org/0009-0001-3449-8527
Jennifer KleinSartorius Stedim Cellca GmbH, Ulm, Germany.ORCID https://orcid.org/0009-0009-1775-7898
Christoph ZeheSartorius Stedim Cellca GmbH, Ulm, Germany.ORCID https://orcid.org/0000-0002-4959-8475
Ann-Cathrin LerouxSartorius Stedim Cellca GmbH, Ulm, Germany.ORCID https://orcid.org/0000-0002-1893-2848

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese hamster ovary (CHO) cells are the primary host for biopharmaceutical production. To meet increasing demands for productivity, quality, and complex molecule expression, genetic engineering, particularly clustered regularly interspaced short palindromic repeats (CRISPR)-mediated gene knockout (KO), is widely used to optimize host cell performance. However, systematic screening of KO targets remains challenging due to the labor-intensive process of generating and evaluating individual clones. In this study, we present a robust, high-throughput CRISPR workflow using stable KO pools in CHO cells. These pools maintain genetic stability for over 6 weeks, including in multiplexed configurations targeting up to seven genes simultaneously. Compared to clonal approaches, KO pools reduce variability caused by clonal heterogeneity and better reflect the host cell population phenotype. We demonstrate the utility of this approach by reproducing the beneficial phenotypic effects of fibronectin 1 (FN1) KO, specifically prolonged culture duration and improved late-stage viability in fed-batch processes. This workflow enables efficient identification and evaluation of promising KO targets without the need to generate and test large numbers of clones. Overall, screening throughput is increased 2.5-fold and timelines are compressed from 9 to 5 weeks. This provides a scalable, efficient alternative to traditional clonal screening, accelerating discovery for CHO cell line engineering for biopharmaceutical development.

Indexed as

Gene EditingGene Knockout TechniquesGenetic TestingAnimalsCHO CellsCricetinaeCricetulusCRISPR-Cas SystemsFibronectinsGenetic EngineeringFibronectinsCHOclonal heterogeneitygenetic engineeringhost cell line engineeringstable CHO pools

Identifiers

PMID40376717
PMCPMC12082383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.